Catalent Pharma Solutions, a provider of advanced technologies and outsourced services to the pharmaceutical, biotechnology and consumer health industry, has received notice that the FDA has approved the sale of a prescription product manufactured in the company's recently opened, pre-filled syringe facility in Brussels, Belgium.

Catalent Pharma Solutions, one of the leading prov

Catalent Pharma Solutions, one of the leading prov

Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced that Wilmington Pharmaceuticals has granted Salix the exclusive, worldwide right to metoclopramide-Zydis®.

Catalent Pharma Solutions, formerly Cardinal Health Pharmaceutical Technologies and Services, today announced its official launch as an independent operating company. The Blackstone Group acquired the business from Cardinal Health in April 2007.